Scroll up to Strategy

Investments

Bain Capital Life Sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe.

AavantiBio
Adagio Therapeutics
Amylyx Pharmaceuticals
annexon
Aptinyx Logo
arcutis
Areteia Therapeutics Logo
atea_logo
Avistone logo
c4_therapeutics
Cardurion Pharmaceuticals
Cerevel Therapeutics
dynavax-Logo
Emalex Biosciences logo
EQRx Logo
freenome
gynesonics
hugel
imperative-care
Interius BioTherapeutics
jenavalve
Jnana logo
Kestra
marinus
mersana
Nautilus Biotechnology
Nimbus Therapeutics
nurix-logo
Nuvalent
pharvaris
rapid-micro-biosystems
River Renal Logo
Rivus Pharmaceuticals
savara
solid-biosciences
SpringWorks Therapeutics
Synthekine
Syros Pharmaceuticals Logo
Tango Therapeutics
x4v2
Xilio Therapeutics

BCLS Acquisition Corp.

BCLS Acquisition Corp. is a newly organized blank check company formed for the purpose of effecting a business combination with one or more biopharmaceutical, specialty pharmaceutical, medical device, diagnostics and enabling life science technology companies.

Click here to visit the website.

Strategy Icon

Our team thinks critically about the issues around hard science, clinical trial design, and the regulatory environment in our investment approach.

Scroll down to People
_
_